logo

For the Inventor, By the Inventor

Sunnyvale, CA, United States of America

Theracos, Inc.


USPTO Granted Patents = 25

% Expired Patents = 64.0



Forward Citations = 130

Loading Chart...
Loading Chart...

42 inventors (with patents filed for the assignee):

goldMedal Brian Seed (15 out of 77 patents)

silverMedal Binhua Lv (10 out of 21 patents)

bronzeMedal Yan Feng (9 out of 23 patents)

4.  Yuanwei Chen (9 out of 17 patents)

5.  Baihua Xu (8 out of 11 patents)

6.  Ge Xu (7 out of 13 patents)

7.  Michael J Hadd (7 out of 14 patents)

8.  Jiyan Du (7 out of 7 patents)

9.  Yuelin Wu (7 out of 7 patents)

10.  Partha Neogi (7 out of 16 patents)

11.  Jacques Y Roberge (7 out of 28 patents)

12.  Shengbin Li (6 out of 6 patents)

13.  Bishwajit Nag (6 out of 42 patents)

14.  Debendranath Dey (5 out of 19 patents)

15.  Huawei Cheng (5 out of 5 patents)


Core Competencies:
SGLT2 Inhibitors
Benzylbenzene Derivatives
Combination Therapy
Crystalline Form
Deuterated Compounds
Glucose Transport Inhibitors
Benzylic Glycosides
Spiroheterocyclic Glycosides
Heterocyclic Analogs
Tricyclic Compounds
Diabetes Treatment
Inflammation Compounds

25 patents:

1. 9193751 - Process for the preparation of benzylbenzene SGLT2 inhibitors (2015-11-24),
2. 9061060 - Deuterated benzylbenzene derivatives and methods of use (2015-06-23),
3. 9006403 - Processes for the preparation of SGLT2 inhibitors (2015-04-14),
4. 8987323 - Crystalline form of benzylbenzene SGLT2 inhibitor (2015-03-24),
5. 8802637 - Benzylbenzene derivatives and methods of use (2014-08-12),
6. 8748419 - [object Object] (2014-06-10),
7. 8735389 - [object Object] (2014-05-27),
8. 8575321 - Benzylbenzene derivatives and methods of use (2013-11-05),
9. 8440655 - Combination therapy for the treatment of diabetes (2013-05-14),
10. 8283454 - Processes for the preparation of SGLT2 inhibitors (2012-10-09),
11. 8129434 - Benzylphenyl cyclohexane derivatives and methods of use (2012-03-06),
12. 8106021 - Benzylbenzene derivatives and methods of use (2012-01-31),
13. 7893053 - [object Object] (2011-02-22),
14. 7838499 - Benzylbenzene derivatives and methods of use (2010-11-23),
15. 7838498 - Benzylic glycoside derivatives and methods of use (2010-11-23),
Company Overview
Theracos, Inc. is a biotechnology company based in Sunnyvale, California, specializing in the development of innovative therapies for chronic diseases. The organization focuses on harnessing advanced research in drug delivery systems and therapeutic modalities to improve patient outcomes. With a commitment to scientific excellence, Theracos aims to address unmet medical needs through its cutting-edge technologies and collaborative research efforts, positioning itself as a leader in the biopharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Theracos, Inc. USPTO Patent Assignee Logo
25 Patents

#158 in Sunnyvale, CA

#3,154 in California

#13,350 in US

#25,681 in the World

Sunnyvale, CA (US)
Sunnyvale, CA, United States of America

Theracos, Inc.

Forward Citations = 130

42 inventors:

goldMedal Brian Seed (15 out of 77 patents)

silverMedal Binhua Lv (10 out of 21 patents)

bronzeMedal Yan Feng (9 out of 23 patents)

4.  Yuanwei Chen (9 out of 17 patents)

5.  Baihua Xu (8 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Theracos, Inc.. Retrieved from https://idiyas.com/company/theracos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…